biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	4C940E44-360D-44CA-9944-5E844B44E308
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9H0-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9H0-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9H0-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104784
biospecimen__bio__day_of_creation	14
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9H0.33EB4235-F58D-4AB6-8944-F2B59374A5F0.pdf
biospecimen__bio__plate_column	9
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	B
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9H0
biospecimen__shared__patient_id	A9H0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	7E213570-71AC-4373-9A76-91898BBE6F37
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	2
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	7598
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	12.2
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__clin_shared__age_at_initial_pathologic_diagnosis	49
clinical__clin_shared__bcr_followup_barcode	TCGA-2Y-A9H0-F69171
clinical__clin_shared__bcr_followup_uuid	D0AC41D4-7565-41E7-8F26-896CE512B5E3
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	207
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2004
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	34bfcf7a-7274-452e-954c-33c3cb18d8e1
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9H0-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	5e036a84-9c4b-480f-b1ed-ac672b5d1de7
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.89
gdc__analytes__analyte_id	44486134-9587-4d8f-b45e-5bcdd401762b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	492ff93f-432b-4b73-8706-632fb2c83eb4
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b16280ae-cb18-5f38-b296-0ae60ebeb550
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1955
gdc__diagnoses__age_at_diagnosis	18109
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-18109.0
gdc__diagnoses__days_to_last_follow_up	3675.0
gdc__diagnoses__diagnosis_id	f3436404-2c73-5216-a8e0-45776bb15b55
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	27.469135802469133
gdc__exposures__exposure_id	7ee29602-651a-5933-a55a-8c1b53be7221
gdc__exposures__height	180.0
gdc__exposures__weight	89.0
gdc__file_id	4a17cf95-d6d4-484c-80ce-7c63fcbd05ed
gdc__file_name	ffff31dd-d2f1-46d9-9af2-0d9ce312719e.mirbase21.mirnas.quantification.txt
gdc__file_size	50381
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	4439a50b8a14b42e002cabc12174bc08
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6fe0bb76-2066-41ed-9525-1535b2c9245d
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	3538
gdc__samples__initial_weight	130.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	33EB4235-F58D-4AB6-8944-F2B59374A5F0
gdc__samples__sample_id	605ef0eb-ebc3-4123-a952-1d1beacba4cd
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	edf70c05-0c74-44bf-a777-45912cde948d
gdc__submitter_id	mirna_swap_dr11_153_MirnaExpression8d41b422-0e30-4699-be22-203332b1f030_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	f640d0bc-bcbf-518f-a6bb-b464572ce690
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:48.271+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/34bfcf7a-7274-452e-954c-33c3cb18d8e1-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/34bfcf7a-7274-452e-954c-33c3cb18d8e1-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129752
manually_curated__local_md5	3a898e11505843e1b38b74b698e03e7a
manually_curated__opengdc_download_date	2018-10-16T17:11:56.000815+02:00
manually_curated__opengdc_file_md5	c2f67c7cb734a9b98e1e70f2908aef61
manually_curated__opengdc_file_size	50380
manually_curated__opengdc_id	34bfcf7a-7274-452e-954c-33c3cb18d8e1-meq
manually_curated__origin_file_size	129752
manually_curated__origin_last_modified_date	Tue Oct 16 17:33:00 CEST 2018
manually_curated__origin_md5	3a898e11505843e1b38b74b698e03e7a
manually_curated__tissue_status	tumoral
